Stocks
Acurx Pharmaceuticals, Inc.ACXP
NASDAQHealthcareBiotechnology$1.14
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing novel antibiotics targeting Gram-positive bacterial infections, including a lead candidate for Clostridioides difficile infection. Its pipeline focuses on addressing antimicrobial resistance, a growing public health concern. Investors track ACXP for its phase 3 clinical data and potential in a niche infectious disease market.
52W Range: $1.07-$7.54
Congressional Interest in Acurx Pharmaceuticals, Inc. (ACXP)
No congressional trades have been disclosed for Acurx Pharmaceuticals, Inc. (ACXP) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ACXP?
No congressional trades found for this stock.